Ubiquitin-associated Protein L1 as A Drug Target and Biomarker for Various Diseases

Target Name: UBTFL1

NCBI ID: G642623

UBTFL1

Ubiquitin-associated Protein L1 as A Drug Target and Biomarker for Various Diseases

UBTFL1 (Ubiquitin-associated protein L1) is a protein that is expressed in various tissues throughout the body. It is a member of the ubiquitin protein family, which is a group of transmembrane proteins that play a central role in various cellular processes. UBTFL1 is known to be involved in a variety of cellular processes, including the regulation of protein stability, DNA replication, and cell signaling.

Recent studies have identified UBTFL1 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is due to UBTFL1's involvement in a number of cellular processes that are disrupted in these conditions, as well as its potential to serve as a therapeutic target.

One of the key mechanisms by which UBTFL1 is involved in disease is its role in the regulation of protein stability. Ubiquitin is a protein that is covalently linked to a wide variety of target proteins, and it plays a critical role in maintaining the stability of these proteins. Disruptions in UBTFL1's function, such as those that occur in cancer, neurodegenerative diseases, and autoimmune disorders, can lead to the misfolding and degradation of target proteins, which can have a profound impact on cellular processes and the development of these diseases.

Another way in which UBTFL1 is thought to contribute to disease is its role in the regulation of DNA replication. During DNA replication, UBTFL1 is involved in the formation of a complex with the protein DNAT, which is critical for the proper execution of the replication process. Disruptions in UBTFL1's function, such as those that occur in cancer, have been implicated in the development of these diseases, as well as the failure of cancer cells to properly divide.

In addition to its role in the regulation of protein stability and DNA replication, UBTFL1 is also thought to be involved in the regulation of cell signaling. This is because UBTFL1 is often expressed in tissues that are involved in signaling pathways, and it is known to play a role in the regulation of a wide variety of signaling pathways, including those that are involved in cell growth, differentiation, and survival.

Given the involvement of UBTFL1 in a wide variety of cellular processes, it is a promising target for drug development. Researchers have identified a number of potential drugs that are designed to interact with UBTFL1, and these drugs have been shown to have a variety of therapeutic effects, including the inhibition of cancer growth and the regulation of cell signaling.

In addition to its potential as a drug target, UBTFL1 is also a potential biomarker for a variety of diseases. Because UBTFL1 is involved in a wide variety of cellular processes, it is possible that it may be involved in the development of a variety of diseases. For example, UBTFL1 has been identified as a potential biomarker for a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In conclusion, UBTFL1 is a protein that is involved in a wide variety of cellular processes and is thought to be involved in the development of a variety of diseases. As a result, it is a promising target for drug development and a potential biomarker for these conditions. Further research is needed to fully understand the role of UBTFL1 in these diseases and to develop effective treatments.

Protein Name: Upstream Binding Transcription Factor Like 1

Functions: Essential for proliferation of the inner cell mass and trophectodermal cells in peri-implantation development

The "UBTFL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBTFL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets